The age-old problem of long-term care
Informal help is a huge share of elder care in U.S., a burden that is only set to expand. A new book explores different countries’ solutions.
Informal help is a huge share of elder care in U.S., a burden that is only set to expand. A new book explores different countries’ solutions.
Since an MIT team introduced expansion microscopy in 2015, the technique has powered the science behind kidney disease, plant seeds, the microbiome, Alzheimer’s, viruses, and more.
A decade of studies provide a growing evidence base that increasing the power of the brain’s gamma rhythms could help fight Alzheimer’s, and perhaps other neurological diseases.
New book from MIT AgeLab researchers applies the concept of innovation clusters to global population aging.
A symposium for financial professionals imagines a new industry around longevity planning.
Albert Almada PhD ’13 studies the mechanics of how stem cells rebuild tissues. “Digging deep into the science is what MIT taught me,” he says.
Jonathan Weissman and collaborators developed a tool to reconstruct human cell family trees, revealing how blood cell production changes in old age.
A speaker series organized by MIT AgeLab explores issues impacting older adults from a variety of backgrounds.
MIT AgeLab annual awards go to high school students who lead or develop intergenerational programs, bringing together younger and older people in their communities.
Seed projects, posters represent a wide range of labs working on technologies, therapeutic strategies, and fundamental research to advance understanding of age-related neurodegenerative disease.
Sharifa Alghowinem, a research scientist at the Media Lab, explores personal robot technology that explains emotions in English and Arabic.
A potential new Alzheimer’s drug represses the harmful inflammatory response of the brain’s immune cells, reducing disease pathology, preserving neurons, and improving cognition in preclinical tests.
MIT PhD student Kathrin Kajderowicz is studying how hibernation-like states could pave the way for new hypothermic therapies.
A new study shows that truncated versions of the Tau protein are more likely to form the sticky filaments seen in the brains of people with Alzheimer’s disease.
MIT researchers characterize gene expression patterns for 22,500 brain vascular cells across 428 donors, revealing insights for Alzheimer’s onset and potential treatments.